Kiniksa Pharmaceuticals International, plc (KNSA)
Healthcare • Drug Manufacturers - Specialty & Generic
StockNasdaqGSUnited KingdomGB00BRXB0C07
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Kiniksa Pharmaceuticals International, plc, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:16. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 23 Feb 2027 08:00 | 0.28 | — | — | Upcoming |
| 27 Oct 2026 07:00 | 0.31 | 0.56 | +79.2% | Beat |
| 28 Jul 2026 07:00 | 0.28 | 0.30 | +5.3% | Beat |
| 28 Apr 2026 07:00 | 0.16 | 0.27 | +68.8% | Beat |
| 24 Feb 2026 07:00 | 0.40 | 0.17 | -57.3% | Miss |
| 28 Oct 2025 07:00 | 0.37 | 0.23 | -37.3% | Miss |
| 29 Jul 2025 07:00 | 0.26 | 0.23 | -11.3% | Miss |
| 29 Apr 2025 07:00 | 0.28 | 0.11 | -61.2% | Miss |
| 25 Feb 2025 07:00 | 0.13 | -0.12 | -192.3% | Miss |
| 29 Oct 2024 07:00 | 0.07 | -0.18 | -366.7% | Miss |
| 23 Jul 2024 07:00 | 0.01 | -0.06 | -999.6% | Miss |
| 23 Apr 2024 07:00 | -0.08 | -0.25 | -212.5% | Miss |
| 28 Feb 2024 07:00 | -0.09 | 0.35 | +488.9% | Beat |
| 31 Oct 2023 07:00 | -0.16 | -0.20 | -25.0% | Miss |
| 25 Jul 2023 07:00 | -0.13 | 0.21 | +261.5% | Beat |
| 02 May 2023 07:00 | -0.16 | -0.18 | -9.1% | Miss |
| 28 Feb 2023 08:00 | -0.14 | 0.06 | +142.9% | Beat |
| 01 Nov 2022 08:00 | 0.83 | 3.18 | +283.1% | Beat |
| 03 Aug 2022 07:00 | -0.39 | -0.29 | +26.3% | Beat |
| 03 May 2022 08:00 | -0.26 | -0.36 | -40.3% | Miss |
| 22 Feb 2022 08:00 | -0.40 | -0.51 | -27.9% | Miss |
| 01 Nov 2021 08:00 | -0.63 | -0.44 | +29.9% | Beat |
| 03 Aug 2021 08:00 | -0.77 | -0.61 | +21.3% | Beat |
| 04 May 2021 08:00 | -0.63 | -0.72 | -14.9% | Miss |
| 23 Feb 2021 08:00 | -0.61 | -0.79 | -30.0% | Miss |
| 05 Nov 2020 07:00 | -0.59 | -0.66 | -11.4% | Miss |
| 30 Jul 2020 07:00 | -0.58 | -0.65 | -11.1% | Miss |
| 28 Apr 2020 08:00 | -0.62 | -0.48 | +22.1% | Beat |
| 26 Feb 2020 07:00 | -0.76 | -0.58 | +23.7% | Beat |
| 28 Oct 2019 16:00 | -0.70 | -0.49 | +29.9% | Beat |
| 12 Aug 2019 16:00 | -0.76 | -0.68 | +10.2% | Beat |
| 02 May 2019 07:00 | -0.79 | -0.73 | +7.8% | Beat |
| 07 Mar 2019 07:00 | -0.74 | -0.88 | -18.6% | Miss |
| 01 Nov 2018 08:00 | -0.53 | -0.51 | +4.7% | Beat |
| 06 Aug 2018 07:00 | -0.50 | -0.47 | +6.9% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 677.6M | +60.1% | 59M | 8.7% | 0.75 | +225.0% | 136.4M |
| 2024 | 423.2M | +56.6% | -43.2M | -10.2% | -0.60 | -400.0% | 25.4M |
| 2023 | 270.3M | +22.7% | 14.1M | 5.2% | 0.20 | -92.3% | 13.2M |
| 2022 | 220.2M | — | 183.4M | 83.3% | 2.60 | — | 5.7M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 95.21 | 99.31 | 93.49 | 95.89 | +2.16% | 2,478,525 | |
| 02 Nov 2026 – 06 Nov 2026 | 92.83 | 96.99 | 87.30 | 93.86 | +1.76% | 4,479,300 | |
| 26 Oct 2026 – 30 Oct 2026 | 76.00 | 98.48 | 70.67 | 92.24 | +20.21% | 8,160,900 | |
| 19 Oct 2026 – 23 Oct 2026 | 78.78 | 84.06 | 76.58 | 76.73 | -2.37% | 3,681,700 | |
| 12 Oct 2026 – 16 Oct 2026 | 80.00 | 82.98 | 76.88 | 78.59 | -1.49% | 3,502,900 | |
| 05 Oct 2026 – 09 Oct 2026 | 75.97 | 80.50 | 73.84 | 79.78 | +5.26% | 1,992,500 | |
| 28 Sep 2026 – 02 Oct 2026 | 75.00 | 76.55 | 73.14 | 75.79 | +0.95% | 3,260,200 | |
| 21 Sep 2026 – 25 Sep 2026 | 77.12 | 79.54 | 74.46 | 75.08 | -2.80% | 2,206,700 | |
| 14 Sep 2026 – 18 Sep 2026 | 77.89 | 79.76 | 74.47 | 77.24 | +1.27% | 3,469,100 | |
| 08 Sep 2026 – 11 Sep 2026 | 76.25 | 80.22 | 75.00 | 76.27 | -2.11% | 2,299,000 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Kiniksa Pharmaceuticals to Present at Jefferies Global Healthcare Conference in London (opens in a new tab) 11 Nov 2026 21:01
- Kiniksa Pharmaceuticals (NASDAQ:KNSA) Clears the Minervini Trend Template but Awaits a Lower-Risk Entry (opens in a new tab) ChartMill · 03 Nov 2026 13:11
- Kiniksa (KNSA) Stock Jumps As Q3 Results Fuel Growth Debate (opens in a new tab) Simply Wall St. · 28 Oct 2026 07:11
- Kiniksa Pharmaceuticals: 3 Key Takeaways for Long-Term Investors (opens in a new tab) Motley Fool · 27 Oct 2026 18:11
- Kiniksa Pharmaceuticals, Ltd. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 27 Oct 2026 17:53
- Kiniksa (KNSA) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 27 Oct 2026 16:43
- What Kiniksa Pharmaceuticals International (KNSA) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 27 Oct 2026 16:04
- Kiniksa Pharmaceuticals International, plc (KNSA) Q3 Earnings and Revenues Surpass Estimates (opens in a new tab) Zacks · 27 Oct 2026 11:50
- Biotech Stocks To Watch: Regeneron Partner Has Breakout In Sight (opens in a new tab) Investor's Business Daily · 14 Oct 2026 21:08
- Kiniksa Pharmaceuticals International (KNSA) On The ARCALYST Story And Whether Shares Look Fully Valued (opens in a new tab) Simply Wall St. · 24 Sep 2026 00:14
- Kiniksa Pharmaceuticals Stock Rallies 41% in Three Months: Here's Why (opens in a new tab) Zacks · 17 Sep 2026 17:13
- Biopharmaceutical Leader Kiniksa Poised To Hit New Buy Point After Big Revenue Beat (opens in a new tab) Investor's Business Daily · 10 Sep 2026 17:35
- Kiniksa's Sales Are Expected To Decline — Why That's All According To Plan (opens in a new tab) Investor's Business Daily · 21 Aug 2026 21:11
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 96.28 USD
- Market cap
- 7.5B
- Exchange
- NasdaqGS
- Country
- United Kingdom
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow KNSA and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.